Radiopharm Theranostics (RADX) Non-Current Assets (2024 - 2025)

Radiopharm Theranostics (RADX) has disclosed Non-Current Assets for 2 consecutive years, with $46.6 million as the latest value for Q2 2025.

  • Quarterly Non-Current Assets fell 5.2% to $46.6 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $46.6 million through Jun 2025, down 5.2% year-over-year, with the annual reading at $46.6 million for FY2025, 5.2% down from the prior year.
  • Non-Current Assets for Q2 2025 was $46.6 million at Radiopharm Theranostics, down from $49.2 million in the prior quarter.
  • The five-year high for Non-Current Assets was $49.2 million in Q2 2024, with the low at $46.6 million in Q2 2025.